numerous studies investigating risk factors for the development of post-operative infection in PCNL patients. Herein, we describe our meta-analysis of the risk factors for the prediction of post-PCNL infectious complications.
Fr ureteral access sheaths, there was no significant difference in ureteral injury rate (7.3% vs 4.6%, respectively; p¼0.63), complications (10.5% vs 11.4%, respectively; p¼0.87), or overall stonefree rate (78.1% vs. 81.3%, p¼0.70). The mean amount of stone burden treated per minute of operative time was more than 30% higher in the 14/16 Fr UAS group compared to 12/14 Fr UAS group (2.11 vs 1.62 mm2/min; p¼0.01).
CONCLUSIONS: The use of a 14/16 Fr UAS allows for similar stone-free rate and improved operative efficiency with no increased risk of ureteral injury or postoperative complications when compared to the 12/14 Fr UAS.
